CATHEJELL 20 MG — DIN 02370840
LIDOCAINE HYDROCHLORIDE : 20 MG · PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H. · GEL · wholesale supply in Canada
Health Canada status: MARKETED
What is CATHEJELL?
CATHEJELL 20 MG contains LIDOCAINE HYDROCHLORIDE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02370840, held by PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H., supplied as GEL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 28-Sep-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CATHEJELL used for?
Surface anesthesia and lubrication for male/female urethra, endoscopic procedures (nasal/pharyngeal), proctoscopy, rectoscopy, tracheal intubation, and symptomatic pain in cystitis/urethritis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Lidocaine cost around the world?
Lidocaine is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 25 | 121 | USD███.██ |
| United Kingdom | hospital | 22 | 22 | GBP███.██ |
| United Arab Emirates | public | 11 | 16 | AED███.██ |
| Bahrain | retail (max) | 11 | 14 | BHD███.██ |
| South Africa | single exit price | 7 | 12 | ZAR███.██ |
| Greece | producer price (ex-factory) | 9 | 9 | EUR███.██ |
| Saudi Arabia | public | 6 | 9 | SAR███.██ |
| Morocco | PPV (public price) | 8 | 8 | MAD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 4 | 4 | EUR███.██ |
| Australia | ex-manufacturer | 3 | 3 | AUD███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| Iceland | max wholesale | 2 | 2 | ISK███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
225 pack listings across 113 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Lidocaine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Lidocaine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
28 holders have a Canadian DIN containing Lidocaine, across 72 DINs, of which 26 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ASPEN PHARMACARE CANADA INC. | 9 | 8 | XYLOCAINE 0.5%, XYLOCAINE 1%, XYLOCAINE 2%, XYLOCAINE JELLY 2%, XYLOCAINE SPRAY, XYLOCAINE VISCOUS 2% | Sourceable in Canada |
| HIKMA CANADA LIMITED | 4 | 4 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Sourceable in Canada |
| AURO PHARMA INC | 4 | 2 | LIDOCAINE INJECTION BP | Sourceable in Canada |
| EUGIA PHARMA INC. | 4 | 2 | LIDOCAINE INJECTION BP | Sourceable in Canada |
| PFIZER CANADA ULC | 4 | 2 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Sourceable in Canada |
| FORMATIVE PHARMA INC. | 2 | 2 | LIDOCAINE HYDROCHLORIDE INJECTION USP | Sourceable in Canada |
| LABORATOIRE AGUETTANT | 2 | 2 | LIDOCAINE HYDROCHLORIDE INJECTION | Sourceable in Canada |
| ODAN LABORATORIES LTD | 2 | 2 | LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY, LIDODAN VISCOUS 2% | Sourceable in Canada |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC 100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4 | 1 | 1 | JELIDO | Sourceable in Canada |
| PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H. | 1 | 1 | CATHEJELL | Sourceable in Canada |
| ALLEGIANCE HEALTHCARE CORPORATION | 7 | 0 | AMNIOCENTESIS TRAY 1%, ARTHROGRAM TRAY 1%, BASIC BIOPSY TRAY 1%, LUMBAR PUNCTURE TRAY 1%, LUMBAR PUNCTURE TRAY 1% PEDIATRIC/INFANT, MYELOGRAM TRAY 1%, THORACENTESIS TRAY 1% | No marketed DIN |
| ASTRAZENECA CANADA INC | 7 | 0 | XYLOCAINE 0.5%, XYLOCAINE 1.5%, XYLOCAINE 2%, XYLOCAINE 2% EPIDURAL, XYLOCAINE 5% SPINAL, XYLOCAINE CO2 INJ, XYLOCAINE TOPICAL 4% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 20 MG |
|---|---|
| Dosage form | GEL |
| Route | TOPICAL |
| Pack configuration (monograph) | 13.3 g pre-filled syringe (expressing approximately 10 g / 9.4 mL). |
| Storage | Not explicitly stated in provided text (Table of Contents lists page 17, but text ends earlier). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Lidocaine |
|---|---|
| ATC code | N01BB02 |
| AHFS class | 72:00.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02370840 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2370840 |
| Brand name | CATHEJELL |
| Generic / active ingredient | LIDOCAINE HYDROCHLORIDE : 20 MG |
| Market authorization holder | PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H. |
| Health Canada schedule | Ethical |
| ATC code | N01BB02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N01BB |
| Current status | MARKETED |
| Status date | 28-Sep-2020 |
| Original market date | 2012-05-25 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Urethral: 5-40g depending on sex/procedure. Endoscopy: 10-20g. Intubation: ~2g to tube surface. Max 4 doses/24h. Children: max 6 mg/kg per dose.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to amide-type local anesthetics; congenital or idiopathic methemoglobinemia; infants <=12 months requiring methemoglobin-inducing agents.
Warnings and precautions
Excessive dosage can cause high plasma levels and serious CNS/cardiovascular toxicity. Risk of methemoglobinemia. Avoid eye contact. Do not use on intact skin. Caution in sepsis/traumatized mucosa.
Is Lidocaine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
26 of 72 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JELIDO | Strength | Gel | PENDOPHARM DIVISION OF PHARMASCIENCE INC 100 6111 Royalmount Ave Montreal Quebec Canada H4P 2T4 | MARKETED | 02469146 |
| LIDOCAINE HYDROCHLORIDE INJECTION | 20 MG | SOLUTION | LABORATOIRE AGUETTANT | MARKETED | 02500655 |
| LIDOCAINE HYDROCHLORIDE INJECTION | 10 MG | SOLUTION | LABORATOIRE AGUETTANT | MARKETED | 02500647 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02422026 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02421992 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | 00884154 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02422018 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | 01901982 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | 02421984 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | FORMATIVE PHARMA INC. | MARKETED | 02534827 |
2 · Same class — other molecules in ATC N01BB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Lidocaine | AMNIOCENTESIS TRAY 1% · ANTECUBITAL CENT VENOUS CATHETERIZATION KIT · ARTHROGRAM TRAY 1% · ATELOCOLLAGEN IMPLANT · BASIC BIOPSY TRAY 1% · CATHEJELL · JELIDO · LARYNG O JET KIT · LIDOCAINE HCL INJ 1% · LIDOCAINE HCL INJ 10MG/ML USP · LIDOCAINE HCL INJECTION USP 1% (50 MG/5ML) · LIDOCAINE HCL INJECTION USP 1% (50MG/5ML) · LIDOCAINE HYDROCHLORIDE INJECTION · LIDOCAINE HYDROCHLORIDE INJECTION USP · LIDOCAINE HYDROCHLORIDE INJECTION USP 0.5% · LIDOCAINE HYDROCHLORIDE INJECTION USP 2% · LIDOCAINE HYDROCHLORIDE INJECTION, USP 1% · LIDOCAINE INJECTION BP · LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY · LIDODAN VISCOUS 2% · LUMBAR PUNCTURE TRAY 1% · LUMBAR PUNCTURE TRAY 1% PEDIATRIC/INFANT · MYELOGRAM TRAY 1% · PERCUTANEOUS SHEATH INTRODUCER KIT HL-09883 · PMS-LIDOCAINE VISCOUS 2% · PREATTACHED LTA KIT · SPINAL ANESTHESIA TRAY 1% · STALLION · THORACENTESIS TRAY 1% · XYLOCAINE 0.5% · XYLOCAINE 1.5% · XYLOCAINE 1% · XYLOCAINE 2% · XYLOCAINE 2% EPIDURAL · XYLOCAINE 5% SPINAL · XYLOCAINE CO2 INJ · XYLOCAINE JELLY 2% · XYLOCAINE MPF · XYLOCAINE MPF 1% · XYLOCAINE SPRAY · XYLOCAINE TOPICAL 4% · XYLOCAINE VISCOUS 2% · XYLOCAINE-MPF, 2% | 72 | 26 | Yes |
| Lidocaine, Combinations | 2% LIDOCAINE AND EPINEPHRINE 1:100,000 INJECTION USP · 5% XYLOCAINE MPF WITH GLUCOSE 7.5% INJECTION · ARROW CENTRAL VENOUS CATHETERIZATION KIT · ARROW MULTI-LUMEN CENTRAL VENOUS CATHETER KIT · ARROW PNEUMOTHORAX KIT · ARROW TWO-LUMEN CENTRAL VENOUS CATHETAR KIT · ARROW TWO-LUMEN JUGULAR CATHETERIZATION KIT · CENTRAL VEIN CATHETERIZATION KIT · CENTRAL VENOUS CATETHERIZATION KIT · CENTRAL VENOUS CATHETER EXPANDED KIT · CONTINUOUS EPIDURAL ANESTHESIA TRAY · DENTSPLY 2% LIDOCAINE WITH EPINEPHRINE 1:100,000 · DENTSPLY 2% LIDOCAINE WITH EPINEPHRINE 1:50,000 · EPIDURAL ANESTHESIA TRAY · EXPANDED MULTI-MED KIT · GENETIC AMNIOCENTESIS TRAY KIT · HYDROCATH CENTRAL VENOUS CATHETER KIT · INSTILLAGEL · JAMSHIDI BONE MARROW BIOPSY TRAY · JAMSHIDI MENGHINI SOFT TISSUE BIOPSY TRAY · LIDOCAINE 2% AND EPINEPHRINE 1:100 000 · LIDOCAINE 2% AND EPINEPHRINE 1:100,000 · LIDOCAINE 2% AND EPINEPHRINE 1:50 000 · LIDOCAINE 2% AND EPINEPHRINE 1:50,000 · LIDOCAINE AND EPINEPHRINE INJ.USP 2% 1:100000 · LIDOCAINE HYDROCHLORIDE 0.5% AND EPINEPHRINE 1:200000 INJECTION USP · LIDOCAINE HYDROCHLORIDE 1.5% AND EPINEPHRINE 1:200000 INJECTION USP · LIDOCAINE HYDROCHLORIDE 1.5% AND EPINEPHRINE 1:200000 INJECTION USP TEST DOSE · LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP · LIGNOSPAN FORTE · LIGNOSPAN SPECIALE INJ · LIGNOSPAN STANDARD · MULTI-LUMEN CENTRAL VENOUS CATHET KIT · OCTOCAINE 100 NEEDLEJECT INJ · OCTOCAINE HCL 2% EPINEPHRINE 1:100000 · OCTOCAINE HCL 2% EPINEPHRINE 1:50000 · PARACENTESIS TRAY W BOASBERG CATHETER SET · PERCUTANEOUS SHEATH INTRO KIT AK-09810-S · PERCUTANEOUS SHEATH INTRODUCER TRAY · PERITONEAL LAVAGE KIT INJ · PLEURA-SEAL THORACENTESIS KIT · PLIAGLIS · SINGLE-SHOT EPIDURAL ANESTHESIA TRAY · SPINAL ANAESTHESIA TRAY · SPINAL ANESTHESIA TRAY · XYLOCAINE - MPF 5% WITH GLUCOSE 7.5% · XYLOCAINE 0.5% W EPINEPHRINE 1:100000 · XYLOCAINE 0.5% W EPINEPHRINE 1:200000 · XYLOCAINE 1.5% W EPINEPHRINE 1:200000 · XYLOCAINE 1.5% W EPINEPHRINE 1:200000 TEST DOSE · XYLOCAINE 1% W EPINEPHRINE 1:100000 · XYLOCAINE 1% W EPINEPHRINE 1:200000 · XYLOCAINE 2% W EPINEPHRINE 1:100000 · XYLOCAINE 2% W EPINEPHRINE 1:200000 · XYLOCAINE 2% WITH EPINEPHRINE 1:200000 · XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000 · XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000 · XYLOCAINE MPF 1.5% WITH EPINEPHRINE · XYLONOR | 72 | 16 | Yes |
| Articaine, Combinations | 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) · 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) · ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION · ORABLOC 1:100,000 · ORABLOC 1:200,000 · POSICAINE N · POSICAINE SP · SEPTANEST N · SEPTANEST SP · ULTRACAINE D-S FORTE INJECTION · ULTRACAINE D-S INJECTION · ULTRACAINE DS FORTE INJ · ULTRACAINE DS INJ · ZORCAINE | 18 | 12 | Yes |
| Bupivacaine | BUPIVACAINE HEAVY INJECTION BP · BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP · BUPIVACAINE HYDROCHLORIDE INJECTION USP · BUPIVACAINE HYDROCHLORIDE INJECTION USP .25% · BUPIVACAINE HYDROCHLORIDE INJECTION USP .50% · BUPIVACAINE HYDROCHLORIDE INJECTION USP .75% · BUPIVACAINE HYDROCHLORIDE INJECTION, USP · BUPIVACAINE INJECTION BP · JAMP-BUPIVACAINE · MARCAINE · MARCAINE 0.25% LIQ PRT 2.5MG/ML · MARCAINE 0.50% LIQ BIN 5MG/ML · MARCAINE 0.75% LIQ PRT 7.5MG/ML · MARCAINE 0.75% LIQ SPINAL 7.5MG/ML · MARCAINE SPINAL · SENSORCAINE | 42 | 10 | Yes |
| Mepivacaine | 3% POLOCAINE DENTAL · CARBOCAINE 1% · CARBOCAINE 2% · CARBOCAINE 3% · CARBOCAINE INJ LIQ 10MG/ML · CARBOCAINE INJ LIQ 20MG/ML · CARBOCAINE LIQ 1% · CARBOCAINE LIQ 2% · ISOCAINE HCL INJ 3% · MEPIVICAINE HYDROCHLORIDE INJECTION, USP 3% · SCANDONEST 3% PLAIN INJ | 15 | 7 | Yes |
| Ropivacaine | NAROPIN · NAROPIN INJ 7.5MG/ML · ROPIVACAINE HYDROCHLORIDE INJECTION · ROPIVACAINE HYDROCHLORIDE INJECTION USP · ROPIVACAINE HYDROCHLORIDE INJECTION, USP · XFUSOR | 13 | 6 | Yes |
| Bupivacaine, Combinations | BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION · MARCAINE · MARCAINE 0.5% AND EPINEPHRINE 1:200,000 LIQ · MARCAINE E · MARCAINE E 0.25% LIQ PRT · MARCAINE E LIQ PRT 0.50% · SENSORCAINE FORTE · SENSORCAINE WITH EPINEPHRINE · VIVACAINE | 12 | 5 | Yes |
| Prilocaine, Combinations | 4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000 · DENTSPLY 4% PRILOCAINE AND EPINEPHRINE INJECTION 1:200,000 · EMLA CREAM · EMLA PATCH · PRILOCAINE HCL 4% EPINEPH 1:200000INJ | 5 | 4 | Yes |
| Combinations | CETACAINE LIQUID · ORAQIX | 2 | 2 | Yes |
| Prilocaine | 4% CITANEST PLAIN DENTAL · DENTSPLY 4% PRILOCAINE HYDROCHLORIDE DENTAL INJECTION | 2 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N01B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N01BA | Benzocaine · Chloroprocaine · Combinations,Of Anesthetics · Procaine · Tetracaine | 13 | 1 |
| N01BX | Phenol | 1 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CATHEJELL called?
The same molecule, Lidocaine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Lignox | Latin | Saudi Arabia |
| VERSATIS | Latin | Bahrain, Czechia |
| Depo-medrol with Lidocaine | Latin | South Africa |
| Lidocaine Eva | Latin | Saudi Arabia |
| PLIAGLIS | Latin | Bahrain |
| Pliaglis® | Latin | United Arab Emirates |
| PRILA | Latin | Bahrain |
| Xylocaine | Latin | Bahrain, South Africa |
| xylocream® | Latin | United Arab Emirates |
| AVOCAINE | Latin | Bahrain |
| BelOcain vet. | Latin | Iceland |
| EMLA | Latin | Bahrain |
| Ennla | Latin | Saudi Arabia |
| Haemoproct | Latin | United Arab Emirates |
| Haemoproct Cream | Latin | United Arab Emirates |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.